Platform
Features
4 followers
Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
Industries
Headquarters
Stage
Employees
Links
John A. Scarlett
20 members
15 members
11 members
5 members
6 members
View all
Roivant Sciences
56 followers
Coherus BioSciences
5 followers
NOCD
3 followers
Axsome Therapeutics
2 followers
BridgeBio
Viz
8 followers
ImmunityBio
Mirati Therapeutics
Dandy
7 followers
Fairlife
1 follower
TG Therapeutics
Discover companies